Recombinant erythropoietin (University of Chile)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant erythropoietin (University of Chile)

Drug Alias NameRecombinant EPOrEPO

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionErythropoietin receptor agonists

TargetsErythropoietin receptor

Therapy Area/IndicationsAnemiaRenal Insufficiency, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Chile

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsAnemiaRenal Insufficiency, Chronic

Inactive IndicationsN/A

ATC CodeN/A